Laboratoire précis Cilia prostate cancer prevention trial risk calculator porcelaine pierre Rareté
Indonesian Prostate Cancer Risk Calculator (IPCRC) An application for Predicting Prostate Cancer Risk (a Multicenter Study)
The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases
PD19-09 COMPARISON OF THE PROSTATE CANCER PREVENTION TRIAL (PCPT) RISK CALCULATOR AND MAGNETIC RESONANCE IMAGING IN SELECTING MEN FOR PROSTATE BIOPSIES | Journal of Urology
IJMS | Free Full-Text | Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis
Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators - European Urology Focus
Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer - ScienceDirect
Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators - ScienceDirect
Indonesian prostate cancer risk calculator (IPCRC) | Download Scientific Diagram
PDF] Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. | Semantic Scholar
xmlinkhub
The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases
Prostate carcinoma- Prostate biopsy
Canadian Tool Better Predicts Prostate Cancer Risk
Basic and Translational Science Body Mass Index Adjusted Prostate-specific Antigen and Its Application for Prostate Cancer Scree
A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc
Risk-Calculator
MP58-17 BLACK-TAILORED PROSTATE BIOPSY RISK CALCULATOR OUTPERFORMS PROSTATE CANCER PREVENTION TRIAL 2.0 | Journal of Urology
Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI
Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator - European Urology Focus
External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort - European Urology Focus
Long-Term Effects of Finasteride on Prostate Cancer Mortality | NEJM
Performance of Prostate Cancer Prevention Trial Risk Calculator in a Contemporary Cohort Screened for Prostate Cancer and Diagno
A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort | BMC Urology | Full Text
Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice
A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort | BMC Urology | Full Text
The Rotterdam Prostate Cancer Risk Calculator decision tree. PSA:... | Download Scientific Diagram
Kaiser Permanente researchers develop new prostate cancer risk calculator – NCAL Research Spotlight